Literature DB >> 32348874

Real time ultrasound molecular imaging of prostate cancer with PSMA-targeted nanobubbles.

Reshani H Perera1, Al de Leon2, Xinning Wang3, Yu Wang4, Gopal Ramamurthy5, Pubudu Peiris6, Eric Abenojar7, James P Basilion8, Agata A Exner9.   

Abstract

Contrast-enhanced ultrasound with microbubbles has shown promise in detection of prostate cancer (PCa), but sensitivity and specificity remain challenging. Targeted nanoscale-contrast agents with improved capability to accumulate in tumors may result in prolonged signal enhancement and improved detection of PCa with ultrasound. Here we report nanobubbles (NB) that specifically targets prostate specific membrane antigen (PSMA) overexpressed in PCa. The PSMA-targeted-NB (PSMA-NB) were utilized to simultaneously image dual-flank PCa (PSMA-positive PC3pip and PSMA-negative PC3flu) to examine whether the biomarker can be successfully detected and imaged in a mouse model. Results demonstrate that active targeting rapidly and selectively enhances tumor accumulation and tumor retention. Importantly, these processes could be visualized and quantified, in real-time, with clinical ultrasound. Such demonstration of the immense yet underutilized potential of ultrasound in the molecular imaging area can open the door to future opportunities for improving sensitivity and specificity of cancer detection using parametric NB-enhanced ultrasound imaging.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Nanobubbles; Prostate cancer; Prostate specific membrane antigen; Ultrasound contrast agents; Ultrasound molecular imaging

Mesh:

Substances:

Year:  2020        PMID: 32348874      PMCID: PMC7605099          DOI: 10.1016/j.nano.2020.102213

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  58 in total

Review 1.  The prostate-specific membrane antigen: lessons and current clinical implications from 20 years of research.

Authors:  Benjamin T Ristau; Denise S O'Keefe; Dean J Bacich
Journal:  Urol Oncol       Date:  2013-12-08       Impact factor: 3.498

2.  Weighing nanoparticles in solution at the attogram scale.

Authors:  Selim Olcum; Nathan Cermak; Steven C Wasserman; Kathleen S Christine; Hiroshi Atsumi; Kris R Payer; Wenjiang Shen; Jungchul Lee; Angela M Belcher; Sangeeta N Bhatia; Scott R Manalis
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

3.  Universal Equations for the Coalescence Probability and Long-Term Size Stability of Phospholipid-Coated Monodisperse Microbubbles Formed by Flow Focusing.

Authors:  Tim Segers; Detlef Lohse; Michel Versluis; Peter Frinking
Journal:  Langmuir       Date:  2017-09-21       Impact factor: 3.882

4.  Preparation and Evaluation of Radiolabeled Antibody Recruiting Small Molecules That Target Prostate-Specific Membrane Antigen for Combined Radiotherapy and Immunotherapy.

Authors:  Afaf R Genady; Nancy Janzen; Laura Banevicius; Mahmoud El-Gamal; Mohamed E El-Zaria; John F Valliant
Journal:  J Med Chem       Date:  2016-03-03       Impact factor: 7.446

5.  Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies.

Authors:  Christian Arsov; Robert Rabenalt; Dirk Blondin; Michael Quentin; Andreas Hiester; Erhard Godehardt; Helmut E Gabbert; Nikolaus Becker; Gerald Antoch; Peter Albers; Lars Schimmöller
Journal:  Eur Urol       Date:  2015-06-23       Impact factor: 20.096

6.  Improving performance of nanoscale ultrasound contrast agents using N,N-diethylacrylamide stabilization.

Authors:  Reshani H Perera; Hanping Wu; Pubudu Peiris; Christopher Hernandez; Alan Burke; Helen Zhang; Agata A Exner
Journal:  Nanomedicine       Date:  2016-08-23       Impact factor: 5.307

Review 7.  Ultrasound of prostate cancer: recent advances.

Authors:  Leo Pallwein; Michael Mitterberger; Alexandre Pelzer; Georg Bartsch; Hannes Strasser; Germar M Pinggera; Friedrich Aigner; Johann Gradl; Dieter Zur Nedden; Ferdinand Frauscher
Journal:  Eur Radiol       Date:  2007-10-16       Impact factor: 5.315

8.  Development of prostate specific membrane antigen targeted ultrasound microbubbles using bioorthogonal chemistry.

Authors:  Aimen Zlitni; Melissa Yin; Nancy Janzen; Samit Chatterjee; Ala Lisok; Kathleen L Gabrielson; Sridhar Nimmagadda; Martin G Pomper; F Stuart Foster; John F Valliant
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

9.  Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics.

Authors:  Kathleen A Cronin; Andrew J Lake; Susan Scott; Recinda L Sherman; Anne-Michelle Noone; Nadia Howlader; S Jane Henley; Robert N Anderson; Albert U Firth; Jiemin Ma; Betsy A Kohler; Ahmedin Jemal
Journal:  Cancer       Date:  2018-05-22       Impact factor: 6.860

10.  Sink or float? Characterization of shell-stabilized bulk nanobubbles using a resonant mass measurement technique.

Authors:  Christopher Hernandez; Eric C Abenojar; Judith Hadley; Al Christopher de Leon; Robert Coyne; Reshani Perera; Ramamurthy Gopalakrishnan; James P Basilion; Michael C Kolios; Agata A Exner
Journal:  Nanoscale       Date:  2019-01-17       Impact factor: 7.790

View more
  12 in total

1.  Development of a novel castration-resistant orthotopic prostate cancer model in New Zealand White rabbit.

Authors:  Yu Wang; Eric C Abenojar; Jing Wang; Al C de Leon; Sidhartha Tavri; Xinning Wang; Ramamurthy Gopalakrishnan; Ethan Walker; Gregory T MacLennan; Anoja Giles; Gregory J Czarnota; James P Basilion; Agata A Exner
Journal:  Prostate       Date:  2022-02-15       Impact factor: 4.104

2.  Bursting Microbubbles: How Nanobubble Contrast Agents Can Enable the Future of Medical Ultrasound Molecular Imaging and Image-Guided Therapy.

Authors:  Agata A Exner; Michael C Kolios
Journal:  Curr Opin Colloid Interface Sci       Date:  2021-05-02       Impact factor: 8.209

3.  Extrusion: A New Method for Rapid Formulation of High-Yield, Monodisperse Nanobubbles.

Authors:  Claire Counil; Eric Abenojar; Reshani Perera; Agata A Exner
Journal:  Small       Date:  2022-05-19       Impact factor: 15.153

4.  Molecular imaging of orthotopic prostate cancer with nanobubble ultrasound contrast agents targeted to PSMA.

Authors:  Yu Wang; Al Christopher De Leon; Reshani Perera; Eric Abenojar; Ramamurthy Gopalakrishnan; James P Basilion; Xinning Wang; Agata A Exner
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

5.  Ultrasound-Based Molecular Imaging of Tumors with PTPmu Biomarker-Targeted Nanobubble Contrast Agents.

Authors:  Mette L Johansen; Reshani Perera; Eric Abenojar; Xinning Wang; Jason Vincent; Agata A Exner; Susann M Brady-Kalnay
Journal:  Int J Mol Sci       Date:  2021-02-17       Impact factor: 5.923

6.  Toward Precisely Controllable Acoustic Response of Shell-Stabilized Nanobubbles: High Yield and Narrow Dispersity.

Authors:  Amin Jafari Sojahrood; Al C de Leon; Richard Lee; Michaela Cooley; Eric C Abenojar; Michael C Kolios; Agata A Exner
Journal:  ACS Nano       Date:  2021-03-08       Impact factor: 15.881

Review 7.  The Application of Nanoparticles in Diagnosis and Treatment of Kidney Diseases.

Authors:  Patrycja Paluszkiewicz; Adrian Martuszewski; Natalia Zaręba; Kamila Wala; Mirosław Banasik; Marta Kepinska
Journal:  Int J Mol Sci       Date:  2021-12-23       Impact factor: 5.923

Review 8.  Nanosized Contrast Agents in Ultrasound Molecular Imaging.

Authors:  Fengyi Zeng; Meng Du; Zhiyi Chen
Journal:  Front Bioeng Biotechnol       Date:  2021-11-29

9.  Intracellular vesicle entrapment of nanobubble ultrasound contrast agents targeted to PSMA promotes prolonged enhancement and stability in vivo and in vitro.

Authors:  Reshani H Perera; Eric Abenojar; Pinunta Nittayacharn; Xinning Wang; Gopal Ramamurthy; Pubudu Peiris; Ilya Bederman; James P Basilion; Agata A Exner
Journal:  Nanotheranostics       Date:  2022-02-14

Review 10.  Biomedical nanobubbles and opportunities for microfluidics.

Authors:  Ali A Paknahad; Liam Kerr; Daniel A Wong; Michael C Kolios; Scott S H Tsai
Journal:  RSC Adv       Date:  2021-10-05       Impact factor: 4.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.